Loading stock data…
WRBY
$24.85+1.34 (+5.70%)
After Hours$24.82-0.03 (-0.12%)· Last close Jun 9
Warby Parker Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Warby Parker Inc. in the Healthcare sector is trading at $24.85. Wall Street consensus targets $29.92 (12 analysts), implying a +20.4% move over the next 12 months. The stock is currently 20% below its 52-week high of $31.00, remaining 3.7% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$24.85
Potential Downside
0%
Whystock Fair Value$24.85
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus12 analysts
Buy
Mean target$29.92+20.4%
Range$24.00 – $35.00
Fundamentals
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tint...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
0.36%
Volume
Today's trading volume
3.89M
Recent News
ATRenew And Two Insider-Favored Growth Stocks To Watch
Over the last 7 days, the United States market has dropped 2.7%, yet it has shown resilience with a 23% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, growth companies with high insider ownership, such as ATRenew and two others we'll explore, can be particularly appealing as they often indicate strong internal confidence in their long-term potential.
Warby Parker (WRBY) Stock Trades Up, Here Is Why
Shares of eyewear retailer Warby Parker (NYSE:WRBY) jumped 4.7% in the morning session after S&P Dow Jones Indices announced the stock will join the S&P SmallCap 600.
Alphabet Bets on Hardware With Googlebook and AI Glasses
Alphabet is expanding into consumer hardware with the Googlebook laptop and Android XR smart glasses, both powered by its Gemini Intelligence AI platform.
3 Prominent Stocks Estimated To Be Trading At Least 14.6% Below Intrinsic Value
Over the last 7 days, the United States market has risen by 1.3%, and over the past year, it has climbed an impressive 28%, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.
The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
Alphabet and Samsung's entry into smart glasses signals a hardware supercycle, challenging Meta's early market lead with EssilorLuxottica.